Tyler Francischine

1 week ago | thenewscaster.com | Tyler Francischine

UF Health researchers propose AI model to predict mortality in coronary artery disease patients University of Florida (UF) Health News By Tyler Francischine Gainesville, Florida — An interdisciplinary team led by University of Florida College of Pharmacy researchers has proposed an artificial intelligence, or AI, model to predict long-term mortality in patients with coronary artery disease.

1 week ago | ufhealth.org | Tyler Francischine

GAINESVILLE, Fla. — An interdisciplinary team led by University of Florida College of Pharmacy researchers has proposed an artificial intelligence, or AI, model to predict long-term mortality in patients with coronary artery disease. The study was published in the Journal of Biomedical Informatics. Characterized by the narrowing of coronary arteries due to the buildup of fatty plaque, , or CAD, limits blood flow to the heart.

2 months ago | thenewscaster.com | Tyler Francischine

April 16, 2025 By Tyler Francischine Gainesville, Florida — A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer’s disease and related dementias in patients with Type 2 diabetes.

2 months ago | ufhealth.org | Tyler Francischine

GAINESVILLE, Fla. — A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer’s disease and related dementias in patients with Type 2 diabetes.

Mar 13, 2025 | ufhealth.org | Tyler Francischine

GAINESVILLE, Fla. — A study led by researchers in the University of Florida College of Pharmacy has found that GLP-1RAs, a class of glucose-lowering medication, may offer antidepressant effects. In a National Institutes of Health-funded study published in the Annals of Internal Medicine on Feb. 25, UF researchers studied Medicare claims data of older adults with Type 2 diabetes to assess their risk of depression while undergoing treatment with either GLP-1RAs, SGLT2is or DPP4is.